<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03092401</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL17_0210</org_study_id>
    <nct_id>NCT03092401</nct_id>
  </id_info>
  <brief_title>Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study</brief_title>
  <acronym>HPS</acronym>
  <official_title>Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hepatopulmonary Syndrome is a respiratory complication of liver cirrhosis defined as a triad:
      hypoxemia (PaO2 &lt; 80 mmHg in room air), chronic liver disease and intrapulmonary
      vasodilatations. Its prevalence varies between 4 and 32%. Numerous treatments have been tried
      but the only efficient therapy to cure the syndrome is liver transplantation. Without
      transplantation it is associated with a higher mortality which is the reason why
      hepatopulmonary syndrome patients have a higher priority to transplantation. However it
      appears in some restricted studies that hepatopulmonary syndrome is associated with more
      postoperative complications (infections, vascular and biliary complications, prolonged length
      of mechanical ventilationâ€¦).

      The investigators hypothesised that hepatopulmonary syndrome patients have more postoperative
      complications after liver transplantation than non hepatopulmonary syndrome patients matched
      on age, MELD (Model for End-Stage Liver Disease) score, comorbidities, perioperative
      transfusion and noradrenaline doses.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 1, 2015</start_date>
  <completion_date type="Anticipated">March 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative complication rates in hepatic transplant patients with or without hepatopulmonary syndrome</measure>
    <time_frame>1 year post liver transplantation</time_frame>
    <description>Collection of medical (cardiac, pulmonary, renal, infectious, neurological) and Surgical (vascular, digestive) complications in hepatic transplant patients with or without hepatopulmonary syndrome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of Mechanical Ventilation</measure>
    <time_frame>1 year post liver transplantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>1 year post liver transplantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>1 year post liver transplantation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delay of hepatopulmonary syndrome resolution</measure>
    <time_frame>1 year post liver transplantation</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">142</enrollment>
  <condition>Hepatopulmonary Syndrome</condition>
  <condition>Liver Cirrhosis</condition>
  <arm_group>
    <arm_group_label>hepatic transplant patients with hepatopulmonary syndrome</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>hepatic transplant patients without hepatopulmonary syndrome</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent liver transplantation between 2010 and 2016
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Liver transplanted patients

        Exclusion Criteria:

          -  Living donor transplantation

          -  Bipartition transplantation

          -  Non-heat-beating donor transplantation

          -  Minor

          -  Double or multiple organ transplantation

          -  Non cirrhotic patients

          -  Retransplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2017</study_first_submitted>
  <study_first_submitted_qc>March 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <last_update_submitted>March 27, 2017</last_update_submitted>
  <last_update_submitted_qc>March 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Liver transplantation</keyword>
  <keyword>Hepatopulmonary Syndrome</keyword>
  <keyword>Liver Cirrhosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
    <mesh_term>Hepatopulmonary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

